Bosch Dividend 2026: Rs 270 cash reward announced for shareholders in Q4 results; profit at Rs 569 crore - Check quarterly earning details - Markets

Bosch Dividend 2026: Rs 270 cash reward announced for shareholders in Q4 results; profit at Rs 569 crore – Check quarterly earning details – Markets

“Recommended a final dividend of Rs 270/- per equity share of ₹10/- each, subject to approval of shareholders. The total dividend payout for the financial year 2025-26 is Rs 270/- per equity share [previous year 512/-(Final) per equity share]. The said final dividend, if declared, by the shareholders at the ensuing Annual General Meeting will…

Read More
RBI revises floating rate savings bond rules: Key changes investors should know

Sammaan Capital Q4 net loss at ₹8,101 crore due to exceptional and impairment charges

Mortgage-focused Sammaan Capital Ltd on Wednesday (May 20) reported a consolidated net loss of ₹8,101.4 crore for the fourth quarter, compared with a loss of ₹324.04 crore in the corresponding period last year. Net interest income (NII) declined 92% year-on-year to ₹84.3 crore from ₹1,057.2 crore. The company reported impairment on financial instruments of ₹2,958.1…

Read More
HG Infra Engineering wins ₹519 crore order from Mirzapur Thermal Energy for railway works

HG Infra removes ₹4,142 crore MSRDC EPC projects from order book pending MSRDC clarity

Infrastructure development company HG Infra Engineering Ltd on Wednesday (May 20) said it has decided not to consider two Maharashtra State Road Development Corporation (MSRDC) projects as part of its executable order book, citing uncertainty over execution and the absence of communication from the authority. The update relates to disclosures made on May 21, 2024,…

Read More
Dr. Reddy's gets one step closer to Semaglutide approval in Canada but Goldman downgrades

Dr Reddy’s launches oral semaglutide biosimilar Obeda for type 2 diabetes in India

Drugmaker Dr Reddy’s Laboratories Ltd on Wednesday (May 20) announced the launch of its oral semaglutide biosimilar in India under the brand name Obeda, indicated for the treatment of type 2 diabetes mellitus. The company said the formulation is based on recombinant DNA (rDNA) origin semaglutide active pharmaceutical ingredient (API). Obeda is available in tablet…

Read More
Ola Electric Q4 Results FY 2026: EV maker posts Rs 500 cr loss, revenue dips 56% to Rs 265 cr - Markets

Ola Electric Q4 Results FY 2026: EV maker posts Rs 500 cr loss, revenue dips 56% to Rs 265 cr – Markets

Namit Singh Sengar is a Chief Copy Editor with over seven years of experience in delivering content across diverse domains. Specialising in business news across personal finance, real estate, IPOs and markets, Namit brings an editorial eye and a deep understanding of complex subjects to his work. His educational foundation includes Post Graduate Diploma in…

Read More
Stock Market Today, May 20: Sensex ends 118 pts higher, Nifty above 23650; factors behind the volatile session, top gainers and losers | Closing Bell - Markets

Stock Market Today, May 20: Sensex ends 118 pts higher, Nifty above 23650; factors behind the volatile session, top gainers and losers | Closing Bell – Markets

Sarmeeli Mallick is a senior journalist with nearly a decade of experience in digital journalism. With a master’s degree in Journalism and Mass Communication from Utkal University, Bhubaneswar, she has a proven track record of impactful reporting, having filed over 19,000 news stories since beginning her career in May 2016. Her diverse background, rooted in…

Read More
Grasim Industries Dividend: 500% per share cash reward in Q4 results; loss stands at Rs 163.5 cr; firm to buy 26% stake in SPV - Markets

Grasim Industries Dividend: 500% per share cash reward in Q4 results; loss stands at Rs 163.5 cr; firm to buy 26% stake in SPV – Markets

Grasim Industries’ board has recommended a dividend of Rs 10 per equity share for the financial year ended March 31, 2026. The dividend, however, is subject to approval of shareholders at the ensuing Annual General Meeting of the company. Read Full Article “Recommended a dividend of 500% at the rate of Rs 10/- (Rupees Ten…

Read More
Investment Strategy at 50: Lump Sum or SIP? 9 funds recommended by expert to plan smart and balance risk - Mutual Funds

Top Stocks to BUY, SELL or HOLD Today: Bharat Electronics, Titan, Indian Oil, Hindalco, Zydus Lifesciences and others – Markets

Top Stocks to BUY, SELL or HOLD Today: Bharat Electronics, Titan, Indian Oil, Hindalco, Zydus Lifesciences and others (Image: AI/ET Now) Top Stocks to BUY, SELL or HOLD Today, May 20: Brokerages remained active across Indian equities on Wednesday, with firms including Morgan Stanley, Goldman Sachs, Motilal Oswal Financial Services and Nuvama Institutional Equities reiterating…

Read More
Top Gainers and Losers Today, 20 May 2026: Bharti Airtel Ltd, lead gains; Nestle India Ltd, Eternal Ltd among top losers - Markets

Top Gainers and Losers Today, 20 May 2026: Bharti Airtel Ltd, lead gains; Nestle India Ltd, Eternal Ltd among top losers – Markets

Get real-time updates on the top gainers and losers across NSE Nifty. Track rising stocks, declining trends, price movements, and sector-wise performance. Stay ahead in the market with key insights from ET Now. Here is the list of stocks that are the Top gainers and Losers stocks during the trading session today – Top-performing stocks…

Read More